Dr. Jeffrey Cummings, a highly respected Alzheimer’s researcher, recently reported that over 99% of drug trials from 2002-2012 for treatment of Alzheimer’s disease have failed to show benefit. What is the current state of drug development? Is research into drug treatments a bottomless money pit or a necessary investment? Join Dr. Brinkman as he discusses this complex topic on the interface of science and politics.
|